BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30594101)

  • 1. Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients.
    Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
    Leuk Res; 2019 Feb; 77():1-4. PubMed ID: 30594101
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of GSTP1 inactivating polymorphism with acute myeloid leukemia and its specific chromosomal abnormalities.
    Daraki A; Zachaki S; Rosmaraki F; Kalomoiraki M; Aleporou-Marinou V; Sambani C; Kollia P; Manola KN
    Leuk Lymphoma; 2017 Oct; 58(10):2505-2507. PubMed ID: 28278696
    [No Abstract]   [Full Text] [Related]  

  • 3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia.
    Bond J; Labis E; Marceau-Renaut A; Duployez N; Labopin M; Hypolite G; Michel G; Ducassou S; Boutroux H; Nelken B; Bertrand Y; Baruchel A; Petit A; Asnafi V; Leverger G; Preudhomme C; Macintyre E; Lapillonne H
    Leukemia; 2018 Aug; 32(8):1878-1882. PubMed ID: 29950694
    [No Abstract]   [Full Text] [Related]  

  • 5. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
    Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
    Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
    Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased miR-144 expression as a non-invasive biomarker for acute myeloid leukemia patients.
    Zhao Q; Li J; Chen S; Shen K; Ai G; Dai X; Xie B; Shi Y; Jiang S; Feng J; Li W
    Pharmazie; 2017 Apr; 72(4):232-235. PubMed ID: 29441994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
    Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
    Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
    Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of cancer-related galectins in acute myeloid leukemia.
    El Leithy AA; Helwa R; Assem MM; Hassan NH
    Tumour Biol; 2015 Sep; 36(10):7929-39. PubMed ID: 25953264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.
    Dong H; Shi P; Zhou Y; Yu Y; Guo X; Yao Y; Liu P; Xu B
    Clin Lab; 2017 Jan; 63(1):85-90. PubMed ID: 28164500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
    Dufour A; Schneider F; Metzeler KH; Hoster E; Schneider S; Zellmeier E; Benthaus T; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Hiddemann W; Bohlander SK; Spiekermann K
    J Clin Oncol; 2010 Feb; 28(4):570-7. PubMed ID: 20038735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
    Kivioja JL; Lopez Martí JM; Kumar A; Kontro M; Edgren H; Parsons A; Lundán T; Wolf M; Porkka K; Heckman CA
    Leuk Lymphoma; 2018 Mar; 59(3):725-732. PubMed ID: 28776436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of a CYP2B6 Gene Polymorphism in Patients with Acute Myeloid Leukemia.
    Alazhary NM; Shafik RE; Shafik HE; Kamel MM
    Asian Pac J Cancer Prev; 2015; 16(11):4583-7. PubMed ID: 26107207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
    Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
    Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.
    Lim TL; Lieberman DB; Davis AR; Loren AW; Hausler R; Bigdeli A; Li Y; Powers J; Raper A; Regeneron Genetics Center ; Carty SA; Nathanson KL; Bagg A; Hexner EO; Maxwell KN; Morrissette JJD; Babushok DV
    Leukemia; 2022 Jan; 36(1):283-287. PubMed ID: 34193977
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.
    de Leeuw DC; Verhagen HJ; Denkers F; Kavelaars FG; Valk PJ; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Leukemia; 2016 Mar; 30(3):742-6. PubMed ID: 26108690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.